Trials / Conditions / Parenteral Nutrition Associated Liver Disease

Parenteral Nutrition Associated Liver Disease

12 registered clinical trials studyying Parenteral Nutrition Associated Liver Disease.

Status	Trial	Sponsor	Phase
Completed	How Well do we Feed the Critically Ill Patients NCT05347888	NMC Specialty Hospital	—
Withdrawn	Safety of Omegaven in Pediatric Patients With Parenteral Nutrition-Associated Cholestasis (PNAC) NCT04807478	Fresenius Kabi	—
Completed	Study of NST-6179 in Healthy Subjects NCT05181085	NorthSea Therapeutics B.V.	Phase 1
Completed	Compassionate Use of Omegaven in the Treatment of Parenteral Nutrition Induced Hepatic Injury NCT02010034	Children's Medical Center Dallas	N/A
Completed	Olive Oil and Soybean 1 Oil Based Intravenous Lipid Emulsions, Liver Chemistry and Clinical Outcomes NCT03442361	University of Calgary	—
Completed	Low Dose Parenteral Fat for Prevention of Parenteral Nutrition Associated Cholestasis in Preterm Neonates NCT01050660	Yale University	N/A
Completed	Use of Omega-3 Fat Emulsion (Omegaven) in Infants With Parenteral Nutrition Associated Liver Disease NCT00862446	Vanderbilt University Medical Center	Phase 4
Unknown	Parenteral Nutrition Associated Liver Disease: Early Markers and Therapy Wih Enteral Omega-3 Supplementation NCT01157780	University of Tennessee	N/A
Completed	Cholestasis Reversal: Efficacy of IV Fish Oil NCT00910104	Mark Puder	Phase 2 / Phase 3
No Longer Available	Omegaven Expanded Access Protocol NCT02121769	St. Luke's Health System, Boise, Idaho	—
No Longer Available	Expanded Access Use of Omegaven® in the Treatment of Parenteral Nutrition Induced Liver Injury in Children NCT02925520	Cook Children's Health Care System	—
Approved For Marketing	Omegaven Protocol:Intermediate Size Patient Population NCT03561194	DHR Health Institute for Research and Development	—